Literature DB >> 19698722

The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.

Terje Sagvolden1, Espen Borgå Johansen, Grete Wøien, S Ivar Walaas, Jon Storm-Mathisen, Linda Hildegard Bergersen, Oivind Hvalby, Vidar Jensen, Heidi Aase, Vivienne A Russell, Peter R Killeen, Tania Dasbanerjee, Frank A Middleton, Stephen V Faraone.   

Abstract

Although several molecular and genetic manipulations may produce hyperactive animals, hyperactivity alone is insufficient for the animal to qualify as a model of ADHD. Based on a wider range of criteria - behavioral, genetic and neurobiological - the spontaneously hypertensive rat (SHR) obtained from Charles River, Germany (SHR/NCrl) at present constitutes the best validated animal model of ADHD combined subtype (ADHD-C), and the Wistar Kyoto substrain obtained from Harlan, UK (WKY/NHsd) is its most appropriate control. Although other rat strains may behave like WKY/NHsd rats, genetic results indicate significant differences when compared to the WKY/NHsd substrain, making them less suitable controls for the SHR/NCrl. The use of WKY/NCrl, outbred Wistar, Sprague Dawley or other rat strains as controls for SHRs may produce spurious neurobiological differences. Consequently, data may be misinterpreted if insufficient care is taken in the selection of the control group. It appears likely that the use of different control strains may underlie some of the discrepancies in results and interpretations in studies involving the SHR and WKY. Finally, we argue that WKY rats obtained from Charles River, Germany (WKY/NCrl) provide a promising model for the predominantly inattentive subtype of ADHD (ADHD-PI); in this case also the WKY/NHsd substrain should be used as control.

Entities:  

Mesh:

Year:  2009        PMID: 19698722      PMCID: PMC2783904          DOI: 10.1016/j.neuropharm.2009.08.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  62 in total

1.  Deriving phenotypes for molecular genetic studies of substance use disorders: a family study approach.

Authors:  Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2006-12-01       Impact factor: 4.492

2.  Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder.

Authors:  R A Barkley; J Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-09       Impact factor: 8.829

3.  Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).

Authors:  Brent Alsop
Journal:  J Neurosci Methods       Date:  2006-12-16       Impact factor: 2.390

4.  Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder.

Authors:  Eve M Valera; Stephen V Faraone; Kate E Murray; Larry J Seidman
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

5.  Infrequent, but not frequent, reinforcers produce more variable responding and deficient sustained attention in young children with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Heidi Aase; Terje Sagvolden
Journal:  J Child Psychol Psychiatry       Date:  2006-05       Impact factor: 8.982

6.  Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder.

Authors:  F Boix; S W Qiao; T Kolpus; T Sagvolden
Journal:  Behav Brain Res       Date:  1998-07       Impact factor: 3.332

7.  Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.

Authors:  Jean-Charles Bizot; Nicolas Chenault; Bérengère Houzé; Alexandre Herpin; Sabrina David; Stéphanie Pothion; Fabrice Trovero
Journal:  Psychopharmacology (Berl)       Date:  2007-04-04       Impact factor: 4.415

8.  The IMAGE project: methodological issues for the molecular genetic analysis of ADHD.

Authors:  Jonna Kuntsi; Benjamin M Neale; Wai Chen; Stephen V Faraone; Philip Asherson
Journal:  Behav Brain Funct       Date:  2006-08-03       Impact factor: 3.759

9.  Origins of altered reinforcement effects in ADHD.

Authors:  Espen Borgå Johansen; Peter R Killeen; Vivienne A Russell; Gail Tripp; Jeff R Wickens; Rosemary Tannock; Jonathan Williams; Terje Sagvolden
Journal:  Behav Brain Funct       Date:  2009-02-18       Impact factor: 3.759

10.  Evidence for impulsivity in the Spontaneously Hypertensive Rat drawn from complementary response-withholding tasks.

Authors:  Federico Sanabria; Peter R Killeen
Journal:  Behav Brain Funct       Date:  2008-02-08       Impact factor: 3.759

View more
  72 in total

1.  Abnormal air righting behaviour in the spontaneously hypertensive rat model of ADHD.

Authors:  Eleanor J Dommett; Claire L Rostron
Journal:  Exp Brain Res       Date:  2011-09-20       Impact factor: 1.972

2.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.

Authors:  Josephine Elia; Joseph T Glessner; Kai Wang; Nagahide Takahashi; Corina J Shtir; Dexter Hadley; Patrick M A Sleiman; Haitao Zhang; Cecilia E Kim; Reid Robison; Gholson J Lyon; James H Flory; Jonathan P Bradfield; Marcin Imielinski; Cuiping Hou; Edward C Frackelton; Rosetta M Chiavacci; Takeshi Sakurai; Cara Rabin; Frank A Middleton; Kelly A Thomas; Maria Garris; Frank Mentch; Christine M Freitag; Hans-Christoph Steinhausen; Alexandre A Todorov; Andreas Reif; Aribert Rothenberger; Barbara Franke; Eric O Mick; Herbert Roeyers; Jan Buitelaar; Klaus-Peter Lesch; Tobias Banaschewski; Richard P Ebstein; Fernando Mulas; Robert D Oades; Joseph Sergeant; Edmund Sonuga-Barke; Tobias J Renner; Marcel Romanos; Jasmin Romanos; Andreas Warnke; Susanne Walitza; Jobst Meyer; Haukur Pálmason; Christiane Seitz; Sandra K Loo; Susan L Smalley; Joseph Biederman; Lindsey Kent; Philip Asherson; Richard J L Anney; J William Gaynor; Philip Shaw; Marcella Devoto; Peter S White; Struan F A Grant; Joseph D Buxbaum; Judith L Rapoport; Nigel M Williams; Stanley F Nelson; Stephen V Faraone; Hakon Hakonarson
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

Review 3.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

4.  Differential expression of SLC9A9 and interacting molecules in the hippocampus of rat models for attention deficit/hyperactivity disorder.

Authors:  Yanli Zhang-James; Frank A Middleton; Terje Sagvolden; Stephen V Faraone
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

5.  Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

6.  Conditioned inhibition in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  John T Green; Amy C Chess; Cynthia J Conquest; Brittney A Yegla
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

7.  Impaired Energy Metabolism and Disturbed Dopamine and Glutamate Signalling in the Striatum and Prefrontal Cortex of the Spontaneously Hypertensive Rat Model of Attention-Deficit Hyperactivity Disorder.

Authors:  Jacqueline J Dimatelis; Jennifer H Hsieh; Toni-Lee Sterley; Lelanie Marais; Jacqueline S Womersley; Maré Vlok; Vivienne A Russell
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

8.  Effect of diet on brain metabolites and behavior in spontaneously hypertensive rats.

Authors:  Ana A Liso Navarro; Elif M Sikoglu; Cailin R Heinze; Ryan C Rogan; Vivienne A Russell; Jean A King; Constance M Moore
Journal:  Behav Brain Res       Date:  2014-05-19       Impact factor: 3.332

9.  A bout analysis of operant response disruption.

Authors:  Ryan J Brackney; Timothy H C Cheung; Federico Sanabria
Journal:  Behav Processes       Date:  2017-04-19       Impact factor: 1.777

10.  The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats.

Authors:  Matthew E Andrzejewski; Robert C Spencer; Rachel L Harris; Elizabeth C Feit; Brenda L McKee; Craig W Berridge
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.